The results showed that high expression of MUC4 was associated with a poor prognosis in ovarian cancer (HR = 1.14, p = 0.0335), brain cancer (HR = 1.42, p = 0.0312), and lung cancer (HR = 1.25, p = 0.0335). Here, MUC4 is linked to ovarian carcinoma.